Blood Glucose Monitor / CGM Devices
Blood glucose monitors and continuous glucose monitoring (CGM) devices are tools used to measure and track blood sugar levels for individuals with diabetes. A standard blood glucose monitor requires a small finger-prick blood sample to provide a reading, while a CGM system uses a small sensor worn on the body to record glucose levels continuously throughout the day and night.
How It Works
Glucose monitoring generally falls into three approaches: capillary blood glucose monitoring (CBG), real-time continuous glucose monitoring (rtCGM), and intermittently-scanned continuous glucose monitoring (isCGM). An rtCGM system uses a small disposable sensor with a filament inserted under the skin that tests glucose levels every few minutes and sends the information to an attached transmitter, and generally on to a separate receiving device such as a smartphone or external reader. Most health insurance plans classify these monitors and CGM devices as eligible medical equipment or diabetic supplies, with coverage that usually reimburses the purchase or replacement of monitors and sensors plus accessories such as test strips, lancets, and transmitters. That benefit may be capped by an annual dollar limit, a reasonable and customary price limit, or a replacement frequency such as one monitor every five years. Coverage is included in many private insurance plans in Canada, though public coverage is inconsistent across the country, and most private insurers reimburse the Dexcom G7 CGM as a pay-direct pharmacy benefit for Canadians on insulin, regardless of diabetes type.
Example:
Suppose a Canadian living with type 1 diabetes has an employer health plan that treats CGM sensors as a pay-direct pharmacy benefit. After their doctor provides a prescription, they pick up replacement sensors at the pharmacy and the insurer reimburses a portion of the eligible cost directly, subject to the plan's coinsurance and any annual maximum. If their province also runs a public glucose monitoring program, that program acts as the payer of last resort and covers part of whatever the private plan does not, so the person should tell the pharmacy about both forms of coverage to coordinate benefits.
What to Watch For:
Some insurers require a physician's prescription or pre-authorization before they will reimburse CGM devices, and plans may apply separate sub-maximums to replacement sensors and transmitters rather than grouping everything under one limit. Because coverage is included in many private plans but public coverage is inconsistent across the country, it helps to confirm what your plan allows. Where a public glucose monitoring program coordinates with private insurance, the public program is typically the payer of last resort, meaning private insurance pays first and any unpaid portion is then sent to the public program.



